Parabilis Medicines (PBLS) AI Analysis

PBLS$30.02-0.35 -1.15%
Market cap$3.66BEnterprise value$2.24BRevenue (TTM)$148,000Market position—

Parabilis Medicines is a growth-led story right now — Growth 93/100 is the pillar doing the heavy lifting (overall 63/100) in Biotechnology. In Biotechnology, that score mix is usable but not one-dimensional. Street targets still imply ~33% upside.

Parabilis Medicines (PBLS) AI Analysis

PBLS price $30.02 -0.35 -1.15%

Ticker
PBLS
Price
$30.02
Change
-0.35 -1.15%
Market cap
$3.66B
Dividend yield
0.00%
Beta
5.03
Sector
Healthcare
Industry
Biotechnology
Stocklytics score
63
Value
55
Quality
40
Growth
93

Stocklytics score rationale: value 55, quality 40, growth 93.

Insights · Forecast · Financials · Learn

Stocklytics home · Screener